Cargando…
Bufotenine, a tryptophan-derived alkaloid, suppresses the symptoms and increases the survival rate of rabies-infected mice: the development of a pharmacological approach for rabies treatment
BACKGROUND: Between 40,000-70,000 people die yearly of rabies, an incurable disease. Besides post-bite vaccination, no treatment is available for it. METHODS: First, virus dilution for antiviral effects in mice was determined. Then, animals were treated as follows: control (NaCl 250 µL/animal/day);...
Autores principales: | Vigerelli, Hugo, Sciani, Juliana M., Pereira, Patricia M. C., Lavezo, Aline A., Silva, Andrea C. R., Collaço, Rita C. O., Rocha, Thalita, Bueno, Thais C., Pimenta, Daniel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Estudos de Venenos e Animais Peçonhentos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996410/ https://www.ncbi.nlm.nih.gov/pubmed/32071597 http://dx.doi.org/10.1590/1678-9199-JVATITD-2019-0050 |
Ejemplares similares
-
Bufotenine is able to block rabies virus infection in BHK-21 cells
por: Vigerelli, Hugo, et al.
Publicado: (2014) -
Synergic effects between ocellatin-F1 and bufotenine on the inhibition of BHK-21 cellular infection by the rabies virus
por: Cunha Neto, Rene dos Santos, et al.
Publicado: (2015) -
Biological Effects and Biodistribution of Bufotenine on Mice
por: Vigerelli, Hugo, et al.
Publicado: (2018) -
In vitro effects of bufotenine against RNA and DNA viruses
por: Barboza, Camila Mosca, et al.
Publicado: (2021) -
Bat Rabies
por: Banyard, Ashley C., et al.
Publicado: (2013)